PharmaResearch Accelerates REJURAN Cosmetics Expansion Across North and South America with Planned Acquisition of CG USA

Why this matters

The planned acquisition of CG USA by PharmaResearch to bolster REJURAN Cosmetics’ manufacturing and logistics footprint across the Americas underscores a broader institutional trend: the intensification of industrial real estate demand driven by consumer-facing supply chain expansion. As brands like REJURAN deepen their presence on major retail and e-commerce platforms, the need for strategically located, scalable industrial assets—particularly those supporting last-mile distribution and regional manufacturing—becomes paramount. This transaction signals continued capital flow into industrial real estate, buoyed by the resilience of logistics and manufacturing amid evolving consumer behaviors and omnichannel retailing. For institutional investors and lenders, the deal highlights the premium placed on industrial properties that can accommodate integrated supply chains, especially in markets spanning North and South America where cross-border logistics complexity is rising. It also suggests that capital allocation strategies may increasingly favor industrial assets tied to high-growth consumer sectors, reflecting confidence in sustained demand despite broader macroeconomic uncertainties. Lending conditions for such assets are likely to remain robust, given their critical role in enabling brand expansion and operational agility.

Editorial analysis · AI-assisted

External link. Real Estate Trail does not republish source content.